336 related articles for article (PubMed ID: 20017729)
1. Cannabinoid-opioid interactions in drug discrimination and self-administration: effect of maternal, postnatal, adolescent and adult exposure to the drugs.
Spano MS; Fadda P; Fratta W; Fattore L
Curr Drug Targets; 2010 Apr; 11(4):450-61. PubMed ID: 20017729
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids, opioids and MDMA: neuropsychological interactions related to addiction.
Robledo P
Curr Drug Targets; 2010 Apr; 11(4):429-39. PubMed ID: 20017726
[TBL] [Abstract][Full Text] [Related]
3. Functional interactions between endogenous cannabinoid and opioid systems: focus on alcohol, genetics and drug-addicted behaviors.
López-Moreno JA; López-Jiménez A; Gorriti MA; de Fonseca FR
Curr Drug Targets; 2010 Apr; 11(4):406-28. PubMed ID: 20196742
[TBL] [Abstract][Full Text] [Related]
4. Endogenous cannabinoid and opioid systems and their role in nicotine addiction.
Maldonado R; Berrendero F
Curr Drug Targets; 2010 Apr; 11(4):440-9. PubMed ID: 20017727
[TBL] [Abstract][Full Text] [Related]
5. The neurobiology of cannabinoid dependence: sex differences and potential interactions between cannabinoid and opioid systems.
Ambrosio E; Martín S; García-Lecumberri C; Crespo JA
Life Sci; 1999; 65(6-7):687-94. PubMed ID: 10462069
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid addiction: behavioral models and neural correlates.
Maldonado R; Rodríguez de Fonseca F
J Neurosci; 2002 May; 22(9):3326-31. PubMed ID: 11978807
[TBL] [Abstract][Full Text] [Related]
7. Cellular mechanisms underlying the interaction between cannabinoid and opioid system.
Parolaro D; Rubino T; Viganò D; Massi P; Guidali C; Realini N
Curr Drug Targets; 2010 Apr; 11(4):393-405. PubMed ID: 20017730
[TBL] [Abstract][Full Text] [Related]
8. Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects.
Ellgren M; Artmann A; Tkalych O; Gupta A; Hansen HS; Hansen SH; Devi LA; Hurd YL
Eur Neuropsychopharmacol; 2008 Nov; 18(11):826-34. PubMed ID: 18674887
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids and reward: interactions with the opioid system.
Fattore L; Cossu G; Spano MS; Deiana S; Fadda P; Scherma M; Fratta W
Crit Rev Neurobiol; 2004; 16(1-2):147-58. PubMed ID: 15581410
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data.
Tanda G; Goldberg SR
Psychopharmacology (Berl); 2003 Sep; 169(2):115-34. PubMed ID: 12827346
[TBL] [Abstract][Full Text] [Related]
11. Role of cannabinoid receptor in the brain as it relates to drug reward.
Yamamoto T; Takada K
Jpn J Pharmacol; 2000 Nov; 84(3):229-36. PubMed ID: 11138722
[TBL] [Abstract][Full Text] [Related]
12. Maternal exposure to delta9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats.
Vela G; Martín S; García-Gil L; Crespo JA; Ruiz-Gayo M; Fernández-Ruiz JJ; García-Lecumberri C; Pélaprat D; Fuentes JA; Ramos JA; Ambrosio E
Brain Res; 1998 Oct; 807(1-2):101-9. PubMed ID: 9757010
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.
Panlilio LV; Justinova Z
Neuropsychopharmacology; 2018 Jan; 43(1):116-141. PubMed ID: 28845848
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoid system and opioid addiction: behavioural aspects.
Fattore L; Deiana S; Spano SM; Cossu G; Fadda P; Scherma M; Fratta W
Pharmacol Biochem Behav; 2005 Jun; 81(2):343-59. PubMed ID: 15935459
[TBL] [Abstract][Full Text] [Related]
15. The opioid systems--panacea and nemesis.
Terenius L; Johansson B
Biochem Biophys Res Commun; 2010 May; 396(1):140-2. PubMed ID: 20494127
[TBL] [Abstract][Full Text] [Related]
16. Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens.
Pickel VM; Chan J; Kash TL; Rodríguez JJ; MacKie K
Neuroscience; 2004; 127(1):101-12. PubMed ID: 15219673
[TBL] [Abstract][Full Text] [Related]
17. Review of addiction risk potential associated with adolescent opioid use.
Windisch KA; Kreek MJ
Pharmacol Biochem Behav; 2020 Nov; 198():173022. PubMed ID: 32871141
[TBL] [Abstract][Full Text] [Related]
18. Effects on development.
Ramos JA; Gómez M; de Miguel R
Handb Exp Pharmacol; 2005; (168):643-56. PubMed ID: 16596791
[TBL] [Abstract][Full Text] [Related]
19. Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl.
Maguire DR; France CP
Eur J Pharmacol; 2016 Aug; 784():199-206. PubMed ID: 27184925
[TBL] [Abstract][Full Text] [Related]
20. Sex-dependent effects of periadolescent exposure to the cannabinoid agonist CP-55,940 on morphine self-administration behaviour and the endogenous opioid system.
Biscaia M; Fernández B; Higuera-Matas A; Miguéns M; Viveros MP; García-Lecumberri C; Ambrosio E
Neuropharmacology; 2008 Apr; 54(5):863-73. PubMed ID: 18329053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
